Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

Group 1 - Apellis Pharmaceuticals will participate in several upcoming investor conferences, including the Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, and Baird Global Healthcare Conference [1] - The dates and times for the conferences are September 3, 2025, at 8:45 a.m. ET, September 4, 2025, at 8:35 a.m. ET, and September 9, 2025, at 10:15 a.m. ET respectively [1] - Live webcasts of the conferences will be available on the company's website, with replays accessible for approximately 30 days post-event [1] Group 2 - Apellis Pharmaceuticals is a global biopharmaceutical company focused on complement science, developing therapies for challenging diseases [2] - The company has introduced the first new class of complement medicine in 15 years, with two C3-targeting medicines approved for four serious diseases [2] - Notable breakthroughs include the first therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients aged 12 and older with C3G or primary IC-MPGN, both severe kidney diseases [2]